VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,056,000 | -23.2% | 417,100 | +29.9% | 0.21% | +28.2% |
| Q3 2016 | $7,885,000 | +92.1% | 321,200 | +57.6% | 0.16% | +18.1% |
| Q2 2016 | $4,104,000 | +54.8% | 203,752 | +102.0% | 0.14% | +76.9% |
| Q1 2016 | $2,652,000 | +53.5% | 100,852 | +1059.2% | 0.08% | +62.5% |
| Q1 2015 | $1,728,000 | -87.8% | 8,700 | -92.8% | 0.05% | -95.0% |
| Q4 2013 | $14,111,000 | -18.1% | 120,200 | -27.2% | 0.96% | -38.1% |
| Q3 2013 | $17,235,000 | -48.0% | 165,200 | -57.1% | 1.56% | -54.2% |
| Q2 2013 | $33,141,000 | – | 385,000 | – | 3.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |